Cetera Advisors’s Aptose Biosciences, Inc. APTO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $35.4K | Sell |
711
-101
| -12% | -$5.03K | ﹤0.01% | 2368 |
|
|
2023
Q4 | $61.1K | Buy |
812
+312
| +62% | +$23.5K | ﹤0.01% | 1731 |
|
|
2023
Q3 | $42K | Buy |
+500
| New | +$42K | ﹤0.01% | 1652 |
|
|
2023
Q2 | – | Sell |
-193
| Closed | -$55.8K | – | 1780 |
|
|
2023
Q1 | $55.8K | Hold |
193
| – | – | ﹤0.01% | 1591 |
|
|
2022
Q4 | $50.4K | Buy |
193
+55
| +40% | +$14.4K | ﹤0.01% | 1544 |
|
|
2022
Q3 | $37K | Hold |
138
| – | – | ﹤0.01% | 1239 |
|
|
2022
Q2 | $46K | Buy |
138
+3
| +2% | +$1K | ﹤0.01% | 1326 |
|
|
2022
Q1 | $83K | Buy |
135
+63
| +88% | +$38.7K | ﹤0.01% | 1364 |
|
|
2021
Q4 | $44K | Buy |
72
+45
| +167% | +$27.5K | ﹤0.01% | 1402 |
|
|
2021
Q3 | $27K | Buy |
27
+4
| +17% | +$4K | ﹤0.01% | 1385 |
|
|
2021
Q2 | $34K | Buy |
+23
| New | +$34K | ﹤0.01% | 1306 |
|